Leerink Swann today maintained an Outperform on Onyx Pharmaceuticals (NASDAQ: ONXX) and raised its price target to $140.00 (from $112) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE